Validation of STARZ Score for Early Neonatal AKI
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-28
SponsorAssiut University
About this trial
Neonatal acute kidney injury (AKI) is a common complication in the NICU, associated with high morbidity and mortality. Prematurity, low birthweight, sepsis, asphyxia, congenital heart disease, and nephrotoxic drugs are major risk factors. Early diagnosis is challenging as serum creatinine lacks sensitivity. The STARZ score, a composite clinical-laboratory tool, has shown high accuracy for predicting early neonatal AKI. This study aims to validate the STARZ score in neonates admitted to Assiut University Children's Hospital for early identification of AKI and improved clinical outcomes."
Eligibility criteria
Qualifiers
Neonates admitted to the NICU within 48 hours of birth.
Gestational age ≥ 28weeks.
Birth weight ≥ 1000grams.
Neonates with clinical indications necessitating laboratory investigations relevant to kidney function monitoring as part of standard care.
Disqualifiers
Neonates with known congenital renal anomalies diagnosed antenatally or postnatally.
Neonates with chromosomal abnormalities or genetic syndromes affecting renal function.
Neonates discharged, transferred, or deceased within 24 hours of admission.
Neonates with incomplete medical records or missing key laboratory data
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov